Beam Therapeutics, Inc. News
Cathie Wood Watch: This Firm Programs Cells, Using DNA as Code
Wood's Ark Investment Management bought a series of biotech stocks, as it has done repeatedly in recent sessions.
Stock Market Today: Inflation Fears Pound Tech, Omicron Wave Tests Growth Bets; Bond Yields Hit 1.8%
Wall Street looks set to extend last week's declines, with tech stocks leading to the downside, ahead of a key reading of December inflation, Jerome Powell testimony and the start of the fourth quarter earnings season.
Beam Therapeutics Stock Active After $1.35 Billion Pfizer Drug Development Deal
Boston-based Beam Therapeutics has agreed to a potential $1.35 billion drug development deal with pharma giant Pfizer.
Intellia Therapeutics Leads Gene-Editing Stock Rally
Intellia Therapeutics rises and other gene-editing stocks follow suit.
Disney Fans Angry, Excited About New Guardians of the Galaxy Ride
The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.
Aurora Cannabis Slashing Weed Capacity in Profitability Push
Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.
Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion
Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.